New York Life Investment Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-8,930
| Closed | -$347K | – | 965 |
|
|
2024
Q1 | $347K | Sell |
8,930
-5,465
| -38% | -$212K | ﹤0.01% | 1291 |
|
|
2023
Q4 | $443K | Sell |
14,395
-446
| -3% | -$13.7K | ﹤0.01% | 920 |
|
|
2023
Q3 | $332K | Sell |
14,841
-2,338
| -14% | -$52.3K | ﹤0.01% | 1057 |
|
|
2023
Q2 | $369K | Sell |
17,179
-2,505
| -13% | -$53.8K | ﹤0.01% | 1111 |
|
|
2023
Q1 | $472K | Sell |
19,684
-8,179
| -29% | -$196K | 0.01% | 1051 |
|
|
2022
Q4 | $646K | Buy |
27,863
+3,144
| +13% | +$72.9K | 0.01% | 722 |
|
|
2022
Q3 | $396K | Buy |
24,719
+1,814
| +8% | +$29.1K | ﹤0.01% | 953 |
|
|
2022
Q2 | $406K | Buy |
+22,905
| New | +$406K | ﹤0.01% | 943 |
|